Daltex Medical Sciences

Daltex Medical Sciences, later known as Specialty Care, Inc., was a biotechnology company focused on the development of antimicrobial technologies for medical devices. The company's core innovation, the "Daltex process," involved impregnating medical polymers with a combination of minocycline and rifampin to prevent healthcare-associated infections. This technology was most notably commercialized through a licensing agreement with Cook Medical for the Spectrum line of antimicrobial catheters. These catheters became a clinical standard for reducing catheter-related bloodstream infections in high-risk patients. Although the company transitioned into a public entity named Specialty Care and eventually ceased active operations, its technology remains a significant contribution to the field of infectious disease prevention. The company's history is also marked by significant legal proceedings regarding the intellectual property and royalty rights of its antimicrobial coatings.